Chronic treatment with the AMPA agonist AICAR prevents skeletal muscle pathology but fails to improve clinical outcome in a mouse model of severe spinal muscular atrophy
Loading...
Files
Date
2016
Other authors
Impact
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Neurotherapeutics, 2016, vol. 13, p. 198-216